Radek Lakomý
- Oncology top 2%
- Molecular Biology top 10%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Hepatology top 2%
- Co-authors
- Ondřej SlabýEric Van CutsemJosep TaberneroJana PrausováPaul RuffVladimir MoiseyenkoCarmen J. AllegraGuy A. Van Hazel
- Topics
- Glioma Diagnosis and Treatment (17 papers)Renal cell carcinoma treatment (16 papers)Cancer Genomics and Diagnostics (13 papers)
- Cited by
- Cancer ResearchHepatologyOncology
- Partner nations
- CzechiaUnited StatesSpain
In The Last Decade
Radek Lakomý
75 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 1.3k
- Molecular Biology 1.2k
- Cancer Research 1.0k
- Pulmonary and Respiratory Medicine 806
- Hepatology 418
Countries citing papers authored by Radek Lakomý
This map shows the geographic impact of Radek Lakomý's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radek Lakomý with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radek Lakomý more than expected).
Fields of papers citing papers by Radek Lakomý
This network shows the impact of papers produced by Radek Lakomý. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radek Lakomý. The network helps show where Radek Lakomý may publish in the future.
Co-authorship network of co-authors of Radek Lakomý
This figure shows the co-authorship network connecting the top 25 collaborators of Radek Lakomý. A scholar is included among the top collaborators of Radek Lakomý based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radek Lakomý. Radek Lakomý is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 5 | |
| 7 | 1 | |
| 8 | 45 | |
| 9 | 10 | |
| 10 | 8 | |
| 11 | 9 | |
| 12 | 15 | |
| 13 | Neoadjuvantní chemoterapie u invazivních uroteliálních nádorů měchýře: korelace léčebné odpovědi a přežití pacientů | 0 |
| 14 | 1 | |
| 15 | 0 | |
| 16 | 10 | |
| 17 | 1 | |
| 18 | Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimenbreakdown → | 986 |
| 19 | Výsledky multimodální léčby glioblastoma multiforme:konsekutivní série 86 pacientů diagnostikovaných v letech2003–2009 | 1 |
| 20 | Intravenous (IF) Aflibercept versus placebo in combination with irinotecan/5-FU (FOLFIRI) for second-line treatment of metastatic colorectal cancer (MCC): Results of a multinational phase III trial (EFC10262-VELOUR) | 39 |
About Radek Lakomý
Radek Lakomý is a scholar working on Cancer Research, Genetics and Oncology, having authored 87 papers that have together received 2.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (17 papers), Renal cell carcinoma treatment (16 papers) and Cancer Genomics and Diagnostics (13 papers). The work is most often cited by research in Cancer Research (1.0k citations), Hepatology (418 citations) and Oncology (1.3k citations). Radek Lakomý has collaborated with scholars based in Czechia, United States and Spain. Frequent co-authors include Ondřej Slabý, Eric Van Cutsem, Josep Tabernero, Jana Prausová, Paul Ruff, Vladimir Moiseyenko, Carmen J. Allegra, Guy A. Van Hazel, Marek Svoboda and David Ferry. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.